Language and Lewy Body Diseases: Sentence Comprehension Problems and Modifying Noninvasive Brain Stimulation Treatment (LANG-LBD)
Lewy Body Disease, Healthy Aging
About this trial
This is an interventional supportive care trial for Lewy Body Disease
Eligibility Criteria
Inclusion Criteria: right-handedness Czech as their first language age (60-80 years) presence of PD-MCI (Litvan et al. 2012) or MCI-LB (McKeith et al. 2020) for LBD subjects Exclusion Criteria: cardio pacemaker any MRI-incompatible metal in the body epilepsy any diagnosed psychiatric disorders alcohol/drug abuse for HC group the presence of LBDs or other neurodegenerative disorder or MCI/dementia
Sites / Locations
- Masaryk University CEITECRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Differences between LBDs patients and HC in regulation of language functions
Long-term effects of repeated sessions of home-based tDCS delivered via telepractice
In this study, 25 LBDs patients and 25 HC will undergo neuropsychological assessment, speech and writing recording, and MRI (structural T1 sequences, sentence comprehension fMRI task, neuromelanin-sensitive MRI sequence, and resting state measurement). The HC group will be matched to the LBDs patients with MCI for gender and age.
The investigators will use a parallel-group, double-blinded, randomized, sham-stimulation-controlled design. Forty LBDs patients will be randomized into two parallel groups, n = 20 subjects in each arm. For the active group, the investigators will use the stimulation protocol with the anode over the left IFG (cathode over the right supraorbital area, 2mA, 20 minutes). Participants will undergo a baseline assessment (A0, as described in arm 1); 10 stimulation sessions (in a two-week period); a follow-up assessment immediately after tDCS treatment (A1), and follow-up assessments 8 weeks (A2) after the baseline assessment. Each assessment will consist of a brief neuropsychological assessment, speech and writing recording and MRI scanning.